| 000 | 01512 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517183558.0 | ||
| 264 | 0 | _c20180629 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a1096-0295 | ||
| 024 | 7 |
_a10.1016/j.yrtph.2017.10.029 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSengupta, Pinaki | |
| 245 | 0 | 0 |
_aAssessment of preclinical pharmacokinetics and acute toxicity of pioglitazone and telmisartan combination. _h[electronic resource] |
| 260 |
_bRegulatory toxicology and pharmacology : RTP _cDec 2017 |
||
| 300 |
_a151-158 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadverse effects |
| 650 | 0 | 4 |
_aBenzimidazoles _xadverse effects |
| 650 | 0 | 4 |
_aBenzoates _xadverse effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xdrug therapy |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
| 650 | 0 | 4 |
_aInsulin _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPPAR gamma _xmetabolism |
| 650 | 0 | 4 | _aPioglitazone |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aTelmisartan |
| 650 | 0 | 4 |
_aThiazolidinediones _xadverse effects |
| 700 | 1 | _aChatterjee, Bappaditya | |
| 700 | 1 | _aPal, Tapan Kumar | |
| 773 | 0 |
_tRegulatory toxicology and pharmacology : RTP _gvol. 91 _gp. 151-158 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.yrtph.2017.10.029 _zAvailable from publisher's website |
| 999 |
_c27758623 _d27758623 |
||